Sage Journals: Discover world-class research

Abstract

With the recognition that smoking begins in youth and that tobacco products are readily available to those under 18 years of age, new Food and Drug Administration (FDA) regulations restrict the sale, distribution, promotion, and advertising of cigarettes to minors. The objective is to decrease the use of tobacco by young people and consequently reduce the future morbidity and mortality from tobacco. Pharmacists currently have three choices with regard to the sale of tobacco in pharmacies: display and sell tobacco products, refuse to sell tobacco products, or make tobacco products available but counsel on smoking cessation. Each choice, as well as the impact of the new FDA regulations on pharmacy, is discussed.

Keywords

tobacco FDA regulations

Get full access to this article

View all access options for this article.

References

Stover

. APhA House of Delegates adopts 13 new policies. J Am Pharm Assoc 1996; 36: 394–6.

US Department of Health and Human Services, Food and Drug Administration. Regulations restricting the sale and distribution of cigarettes and smokeless tobacco to protect children and adolescents, final rule. Federal Register 1996; 61: 396–618.

Neergaard

. Liggett tobacco company admits danger. Internet, Thursday, March 20, 1997 (CBS Evening News, March 22, 1997).

Arno

Brandt

Gostin

Morgan

. Tobacco industry strategies to oppose federal regulation. JAMA 1996; 275: 1258–62.

US Department of Health and Human Services. The health consequences of involuntary smoking: a report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, 1988.

US Department of Health and Human Services. The health consequences of smoking, nicotine addicition: a report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, 1988.

Gostin

Arno

Brandt

. FDA regulation of tobacco advertising and youth smoking. JAMA 1997; 277: 410–8.

Tobacco use and usual source of cigarettes among high school students: United States, 1995. MMWR Morb Mortal Wkly Rep 1996; 45: 413–8.

Rumore

Tsamboukos

Reddy

. Should FDA regulate tobacco as a drug? J Pharm Law 1996; 5: 285–307.

10.

Sachs

. Letters tell FDA to butt out. Advert Age 1995; Oct. 23: 54.

11.

Womach

. Tobacco price supports — An overview of the program. Congressional Research Service, Library of Congress, Washington, DC, March 16, 1994.

12.

Centers for Disease Control and Prevention, US Department of Health and Human Services. Medical care expenditures attributable to cigarette smoking, US, 1993. MMWR Morb Mortal Wkly Rep 1994; 434: 469–72.

13.

Conlan

. FDA cracking down on retail stores over tobacco sales. Drug Topics 1997; March 3: 117.

14.

Drug topics business outlook survey. Drug Topics 1996; Dec. 9:14–6.

15.

Brown

DiFranza

. Pharmacy promotion of tobacco use among children in Massachusetts. Am Pharm 1992; 32: 45–8.

16.

Students and tobacco, the 1990 Nova Scotia Council on Smoking and Health Survey, final report. Nova Scotia Council on Smoking and Health, 1991;March:20.

17.

McCormick

. Sell tobacco products? Pharmacist opinion poll. Pharm Times 1992; April: 73–4.

18.

Department of Health and Human Services, Food and Drug Administration. Children and tobacco — A retailer's guide to the new federal regulations, FDA. Rockville, MD: Food and Drug Administration, 1996.

19.

Code of Ethics for Pharmacists (adopted by the membership of the American Pharmaceutical Association, October 27, 1994). Washington, DC: American Pharmaceutical Association, 1994.

20.

Smith

. The role of pharmacists in smoking cessation counseling. Drug Topics 1989; (suppl):2–27.

Pharmacy and Tobacco

Abstract

Keywords

Get full access to this article

References